Each enteric-coated tablet contains 25 mg or 50 mgor 100mgdiclofenacsodium.
Antirheumatics (Anti-inflammatory Agents)andAntipyretic analgesics.
Diclofenac sodium is a non-steroidal compound, a phenylacetic acid
derivative, with analgesic, antipyretic and anti-inflammatory
effects. Diclofenac sodium inhibits the biosynthesis and release of
prostaglandins, which are known to be implicated in the
pathogenesis of inflammation, pain and fever. LANSAFENAC Tablets
are enteric-coated so that absorption occurs in the
gastrointestinal tract to give peak plasma concentrations
approximately 2 hours after ingestion. There is at least 99%
binding to plasma-proteins and excretion of metabolites is mainly
in the urine.
DOSAGE AND DIRECTIONS FOR USE:
Usual Adult Dose:
25 to 50 mg taken three times daily. The tablet must be taken whole
during or after meals. Initially this dose may be increased to 150
mg daily and may be reduced to 75 to 100 mg daily in milder cases
or for long-term and maintenance therapy. Diclofenac sodium is not
recommended for use in children as safety and efficacy have not
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
In view of the product’s inherent potential to cause fluid
retention, heart failure may be precipitated in some compromised
Gastric or intestinal ulceration with associated bleeding has been
reported - LANSAFENAC therapy should be discontinued immediately in
such cases. Skin rashes and gastro-intestinal disturbances may
occur. Headache, dizziness, oedema, nervousness, pruritus,
tinnitus, insomnia, blurred vision and other ocular reactions,
peripheral oedema, malaise, jaundice, elevated transaminase levels,
drowsiness and hypersensitivity reactions (eg. bronchospasm) have
occurred. Blood counts and monitoring of hepatic and renal function
are advised during prolonged therapy with LANSAFENAC as blood
dyscrasias have been reported. LANSAFENAC should be given with care
to patients with bleeding disorders, cardiovascular disease, and in
those who are receiving coumarin anticoagulants. Patients who are
sensitive to aspirin generally should not be given LANSAFENAC.
25 mg tablet: round,enteric-coated.
50 mg tablet: round, enteric-coated.
100 mg tablet:round, enteric-coated.
LANSAFENAC 25 mg Tablets arepackaged in box with 10tablets or 100 tablets
LANSAFENAC 50 mg Tablets arepackaged in box with 10tablets or 100 tablets
LANSAFENAC100 mg Tablets arepackaged in box with 10tablets or 100 tablets
Store below 25°C. Protect from light and moisture. Keep out of
reach of children.